|
Volumn 18, Issue 9, 2005, Pages 1116-
|
Interleukin 2 receptor blockers may directly inhibit lymphocyte mediated ischaemia reperfusion injury [1]
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CALCINEURIN INHIBITOR;
CREATININE;
DACLIZUMAB;
INTERLEUKIN 2 RECEPTOR;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISOLONE;
TACROLIMUS;
IMMUNOGLOBULIN G;
MONOCLONAL ANTIBODY;
CELLULAR IMMUNITY;
CLINICAL TRIAL;
CREATININE BLOOD LEVEL;
DELAYED HYPERSENSITIVITY;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY DONOR;
KIDNEY ISCHEMIA;
KIDNEY TRANSPLANTATION;
LETTER;
LYMPHOCYTE;
LYMPHOCYTIC INFILTRATION;
NEUTROPHIL;
PRIORITY JOURNAL;
RENAL GRAFT DYSFUNCTION;
REPERFUSION INJURY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG ANTAGONISM;
IMMUNOLOGY;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
ANTIBODIES, MONOCLONAL;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSION;
KIDNEY TRANSPLANTATION;
LYMPHOCYTES;
RECEPTORS, INTERLEUKIN-2;
REPERFUSION INJURY;
|
EID: 26944489293
PISSN: 09340874
EISSN: 14322277
Source Type: Journal
DOI: 10.1111/j.1432-2277.2005.00180.x Document Type: Letter |
Times cited : (6)
|
References (6)
|